Parabilis Medicines Stock Forecast

Buy or Hold candidate since Jul 21, 2026 Gain 18.94%

The Parabilis Medicines, Inc. stock price gained 2.14% on the last trading day (Monday, 10th Aug 2026), rising from $34.98 to $35.73. During the last trading day the stock fluctuated 5.73% from a day low at $34.93 to a day high of $36.93. The price has risen in 6 of the last 10 days and is up by 12.29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 127 thousand more shares were traded than the day before. In total, 393 thousand shares were bought and sold for approximately $14.05 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $36.82 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 36.76% during the next 3 months and, with a 90% probability hold a price between $40.57 and $50.36 at the end of this 3-month period.

PBLS Signals & Forecast

The Parabilis Medicines, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $35.00 and $30.78. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -0.474%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Parabilis Medicines, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $31.60 and $30.31. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Parabilis Medicines, Inc. finds support just below today's level at $31.60. If this is broken, then the next support from accumulated volume will be at $30.31 and $27.26.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.00 between high and low, or 5.73%. For the last week, the stock has had daily average volatility of 6.70%.

Our recommended stop-loss: $34.41 (-3.69%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (PBLS) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Parabilis Medicines, Inc. to open at $35.86, and during the day (based on 14 day Average True Range), to move between $34.47 and $36.99, which gives a possible trading interval of +/-$2.51 (+/-7.29%) up or down from last closing price. If Parabilis Medicines, Inc. takes out the full calculated possible swing range there will be an estimated 7.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $35.90 (0.48%) than the support at $31.60 (11.56%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Parabilis Medicines, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Parabilis Medicines, Inc. stock to perform well in the short-term.

Current score: 1.643 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $35.86 ( 0.373%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk